• Nenhum resultado encontrado

Rev. Bras. Hematol. Hemoter. vol.37 número6

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Bras. Hematol. Hemoter. vol.37 número6"

Copied!
3
0
0

Texto

(1)

rev bras hematol hemoter. 2 0 1 5;37(6):423–425

w w w . r b h h . o r g

Revista

Brasileira

de

Hematologia

e

Hemoterapia

Brazilian

Journal

of

Hematology

and

Hemotherapy

Letter

to

the

Editor

Diagnostic

approach

to

hemolytic

anemias

in

the

adult

DearSir,

Eventhoughhemolyticanemias(HAs)arenotverycommon, their diagnosis remains a big challenge for hematologists and clinicians.Wehopethat this summarywillcontribute withvaluableinformationaboutasubjectthathasbeen lit-tledescribedinthemedicalliterature,andwillhelptoclarify thediagnosticapproachtoguidespecifictreatmentdepending onthecausativecondition.

ItisknownthatHAsare agroupofdisorders character-izedbyaprematureredbloodcell(RBC)destruction(lessthan 120days),1,2 thatexceedsthecompensatorycapacityofthe bonemarrowtoincreaseRBC productionandkeepupwith the loss.1–3 Usually HAs are diagnosed through laboratory tests,however, the patient’shistory and physical examina-tionarecrucialastheyprovideimportantinformationabout the presenceof hemolysis and its probable etiology.3,4 For example,ifinaddition tothe classicsymptomsofanemia (paleness, fatigue, dyspnea, palpitations), findings such as familialorpersonalhistoryofjaundice,exposuretotoxics,leg ulcers,lymphadenopathies,hepatomegaly or splenomegaly mayhelptoelucidatethecauseoftheanemia.1,3,4

Regardingtheetiology,HAscanbeclassifiedasinherited oracquiredandwhenconsideringthesiteofhemolysis,RBCs canbedestroyedinthecirculation(intravascular)orwithin macrophagesinthespleenorliver(extravascular).Fromthe clinicalperspective,HAscanbeacuteorchronicandaccording tothelocationoftheabnormalityresponsibleforthe hemoly-sis,theymaybeduetointrinsic(intracorpuscular)orextrinsic (extracorpuscular)defects.2–4Itisimportanttomentionthat mostintrinsicdefectsareinherited,andmostextrinsicones areacquired,2however,therearesomeexceptionstothisrule. Forexample,paroxysmalnocturnalhemoglobinuria(PNH)is anacquiredHAproducedbyanintrinsicdefect4and glucose-6-phosphatedehydrogenase(G6PD)deficiencyisaninherited intrinsicdefectthatistriggeredbyanexternalfactor.2

Althoughtherearedifferentwaysofapproachingthe diag-nosisofHAs,itisfirstnecessarytoidentifythepatientwithHA andcollectdataonhemolysis.ThedestructionofRBCsinHAs ischaracterizedbyanincreasedbreakdown ofhemoglobin

whichresultsinunconjugatedhyperbilirubinemiaclinically evidencedbyjaundice,increasedlactatedehydrogenase (cel-lular destruction), and reticulocytosis, which is a normal compensatory response of the bone marrow to the RBC loss.Additionally,decreasedlevelsofplasmahaptoglobin,a markerofRBC destruction, areevidenced1–3 regardlessthe site ofhemolysis(intravascularor extravascular).5 Incases ofsevere acute intravascular HAs, the haptoglobin-binding capacityreachesitssaturationpoint,andfreehemoglobinis filteredbytheglomerulusandhemoglobinuriaisseen.3,6Also, hemosiderinuriamaybepresentinlong-termintravascular hemolysis.3,6Ontheotherhand,ifthehemolysisis extravas-cular,urobilinogenmayappearintheurineorfeces.6

Oncewehaveapresumptivediagnosis,amulti-step pro-cedureisrequired,4beginningwithadirectantiglobulintest (DAT) or direct Coombs test.6,7 This isthe exam ofchoice becauseitwillclassifythehemolysisintoanimmuneor non-immune etiology.6,7 AlthoughDAT helps tocategorize HAs into twogroups,resultsmustbeinterpretedinthe context oftheclinicalconditionsassomeconditionsmaybe incor-rectlyclassified.7,8 Thisiswhythe DATshould befollowed byaperipheralbloodsmear(PBS)andaninvestigationofthe familyhistory.6AsimpleapproachtoidentifyandclassifyHAs basedontheworksofGonzálezMesonesetal.6andothers3,4,8 ispresentedinFigure1.

(2)

424

rev

bras

hema

tol

hemoter.

2

0

1

5;

3

7(6)

:423–425

Table1–Themostcommoncausesofhemolysisclassifiedbytype.

Defect

Intrinsic Inherited

Enzymopathies

Hemoglobinopathies

Membranopathies

Immune-mediated

Acquired

Traumatic

Infectious

Toxic

Entrapment

Endogenous Exogenous Small Vessels

Big Vessels Drug-induced Alloimmunization

Autoimmune hemolytic anemia

hemolytic anemia Extrinsic

Etiology Abnormality Examples

G6PD deficiency, pyruvate kinase deciciency

Thalassemia, sickle cell anemia Hereditary spherocytosis, elliptocytosis

Nocturnal paroxysmal hemoglobinuria Warm antibodies [IgG]

Idiopathic, lymphoproliferative (CLL, NHL), SLE, non-lymphoid

malignancies Cold antibodies [IgG]

mononucleosis, lymphoproliferative (Waldenstroms), paroxysmal cold hemogloburina

Mixed [warm and cold antibodies] Idiopathic, SLE, lymphoma ABO incompatibility

By haptens

By autoantibodies

By immune complexes

Quinidine, hydrochlorothiazide, sulfonamides, tetracycline Prostheses

diclofenac

Valves, TIPS

Microangiophatic hemolytic anemia TTP, HUS, HELLP, DIC Bartonella, Babesia, Plasmodium

Clostridium

Arsenic, lead or copper poisoning Snake or spider bite

Wilson disease

Hypersplenism

Alpha-methyldopa, L-dopa, ibuprofen, Penicillin, cephalosporin

Idiopathic, M. pneumoniae, •

Site of hemolysis

EV

EV IV

IV

IV

EV IV

EV

IV

IV

IV

IV

IV EV

EV

EV (also EV)

or EV

G6PD:glucose-6-phosphatedehydrogenase;CLL:chroniclymphocyticleukemia;NHL:non-Hodgkinlymphoma;SLE:systemiclupuserythematous;TIPS:

transjugularintrahepaticportosystemicshunt;TTP:thromboticthrombocytopenicpurpura;HUS:hemolyticuremicsyndrome;HELLP:hemolysis,elevated

(3)

revbrashematolhemoter.2015;37(6):423–425

425

Patient with anemia and characteristic laboratory features of hemolysis

DAT

[+] mediated HA

Immune-Autoimmune HA

Warm antibodies

Cold antibodies

Mixed

Alloimmunization incompatibilityABO

Drug-induced HA

By haptens

By autoantibodies

By immune complexes

[–] Nonimmune-mediated HA Peripheral blood smear

[+] Family history

[+] Congenital HA

Enzymopathies

Hemoglobinopathies

Membranopathies

[–]

Traumatic

Big vessels

Small vessels

Infectious

Toxic

Exogenous

Endogenous PNH

Hypersplenism [–]

Figure1–Asimpleapproachtoidentifyandclassifyhemolyticanemias.DAT:directantiglobulintest;HA:hemolytic

anemia;PNH:paroxysmalnocturnalhemoglobinuria.

acongenitalHAincludingdisordersofenzymes(G6PD defi-ciency,pyruvatekinasedeficiency)hemoglobin(thalassemia, sicklecellanemia)or ofthe membrane(hereditary sphero-cytosis,elliptocytosis).Likewise,traumatichemolysis(ofbig orsmallvessels),infectious(Bartonella,Babesia,Plasmodium)or toxic(exogenousorendogenous)pathologiesshouldbetaken intoaccountifthereisanabnormalPBSintheabsenceof fam-ilyhistory.Incontrast,ifthePBSisnormal,hypersplenismor PNHshouldbeconsidered.Adetailedlistofthemostcommon causesofhemolysisclassifiedbytypeispresentedinTable1.

Conflicts

of

interest

Theauthorsdeclarenoconflictsofinterest.

r

e

f

e

r

e

n

c

e

s

1.EvansER.Diagnosisofthehemolyticanemias.CalifMed. 1951;75(4):271–5.

2.UcarK.Clinicalpresentationandmanagementofhemolytic anemias.Oncology(WillistonPark).2002;169(Suppl10):163–70.

3.DhaliwalG,CornettPA,TierneyLMJr.Hemolyticanemia.Am FamPhysician.2004;69(11):2599–606.

4.GuillaudC,LoustauV,MichelM.Hemolyticanemiainadults: maincausesanddiagnosticprocedures.ExpertRevHematol. 2012;5(2):229–41.

5.ShihAW,McFarlaneA,VerhovsekM.Haptoglobintestingin hemolysis:measurementandinterpretation.AmJHematol. 2014;89(4):443–7.

6.GonzálezMesonesB,GonzálezdeVillambrosiaA,BatlleA, InsunzaA.Protocolodiagnósticodelasanemiashemolíticas. Medicine.2012;11(20):1246–9.

7.ZantekND,KoepsellSA,TharpDRJr,CohnCS.Thedirect antiglobulintest:acriticalstepintheevaluationofhemolysis. AmJHematol.2012;87(7):707–9.

8.BassGF,TuscanoET,TuscanoJM.Diagnosisandclassification ofautoimmunehemolyticanemia.AutoimmunRev. 2014;13(4–5):560–4.

EloyF.Ruiz∗, MiguelA.Cervantes

UniversidadPeruanaCayetanoHeredia,Lima,Peru

Correspondingauthorat:Av.ElPolo740,EdificioC,Oficina313,

SantiagodeSurco,Lima,Peru.

E-mailaddress:eloy.ruiz.m@upch.pe(E.F.Ruiz).

Received26June2015 Accepted19August2015 Availableonline9October2015

http://dx.doi.org/10.1016/j.bjhh.2015.08.008

Imagem

Figure 1 – A simple approach to identify and classify hemolytic anemias. DAT: direct antiglobulin test; HA: hemolytic anemia; PNH: paroxysmal nocturnal hemoglobinuria.

Referências

Documentos relacionados

1 The aims of these stages are numer- ous but include improving donor awareness and trust in the blood transfusion service, encouragement to adhere to the donor selection

Clostridium difficile infection after adult autologous stem cell transplantation: a multicenter study of epidemiology and risk factors. Biol Blood

Figure 3 – Leukemia-free survival according to minimal residual disease based on real-time quantitative polymerase chain reaction at the end of induction in 44 children with

The exclusion criteria were (1) donors who were previously aware of their serological status for HBV and HCV; (2) donors with positive serologic screening tests for human

Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality. Bone

Therefore, this study does not support data published for patients without neutropenia; the CD64 index was not able to predict positive blood culture results in this specific

Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease – a randomized, controlled,

positive precursor B-cell acute lymphoblastic leukemia with positive minimal residual disease (0.32%) before conditioning treatment for hematopoietic stem cell transplantation..